EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.10.1.1 | Alzheimer Disease |
33423317 |
Is SGSH heterozygosity a risk factor for early-onset neurodegenerative disease? |
unassigned |
0 |
3.10.1.1 | arylsulfatase (type i) deficiency |
118467 |
Genetic complementation studies of multiple sulfatase deficiency. |
causal interaction unassigned |
1 0 |
3.10.1.1 | arylsulfatase (type i) deficiency |
9880143 |
Pathologic findings of multiple sulfatase deficiency reflect the pattern of enzyme deficiencies. |
causal interaction unassigned |
4 0 |
3.10.1.1 | beta-glucuronidase deficiency |
20084460 |
Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones. |
causal interaction unassigned |
3 0 |
3.10.1.1 | beta-Mannosidosis |
1861455 |
Complementation studies in human and caprine beta-mannosidosis. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 2 1 1 |
3.10.1.1 | Deficiency Diseases |
116130 |
Is multiple sulphatase deficiency due to defective regulation of sulphohydrolase expression? |
causal interaction unassigned |
4 0 |
3.10.1.1 | Genetic Diseases, Inborn |
25142140 |
High and prolonged sulfamidase secretion by the liver of MPS-IIIA mice following hydrodynamic tail vein delivery of antibiotic-free pFAR4 plasmid vector. |
causal interaction unassigned |
4 0 |
3.10.1.1 | Infections |
26620043 |
Continual Low-Dose Infusion of Sulfamidase Is Superior to Intermittent High-Dose Delivery in Ameliorating Neuropathology in the MPS IIIA Mouse Brain. |
causal interaction ongoing research therapeutic application unassigned |
2 3 1 0 |
3.10.1.1 | Intellectual Disability |
31385193 |
Bioinformatics classification of mutations in patients with Mucopolysaccharidosis IIIA. |
causal interaction unassigned |
4 0 |
3.10.1.1 | Leukemia |
8930656 |
Correction of Sanfilippo A skin fibroblasts by retroviral vector-mediated gene transfer. |
ongoing research unassigned |
3 0 |